-
Mashup Score: 1Program Guide – ASCO Meeting Program Guide - 8 day(s) ago
Joseph Park Duke University, Durham, NC Joseph Park, Lauren Howard, Stamatina Fragkogianni, Daniel George, Andrew Armstrong Duke University, Durham, NC, Department of Biostatistics and Bioinformatics, Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University School of Medicine, Durham, NC, Tempus AI, Inc., Chicago, IL, Duke Cancer Institute Center for Prostate & Urologic Cancers, Durham, NC Inactivating missense mutations in the tumor suppressor gene speckle-type POZ (SPOP) increase
Source: meetings.asco.orgCategories: General Medicine NewsTweet
-
Mashup Score: 5Program Guide – ASCO Meeting Program Guide - 8 day(s) ago
Matthew West Tempus AI, Inc, Chicago, IL Matthew West, Samuel Heilbroner, Sai Prabhakar Pandi Selvaraj, Hannah Weiss, John Yazbek, Peter Halloran, Abigail Koornwinder, Gabriel Altay, Nick Pojman, Jesus Pedrosa, Victoria Chiou, Arpita Saha Tempus Lens is a hosted web application that allows users to query multimodal data from millions of de-identified patient records in the Tempus Database. Patient inclusion/exclusion criteria are represented by filters, a group of which constitute a query. Lens has
Source: meetings.asco.orgCategories: General Medicine NewsTweet-
Cohort builder in Tempus Lens: Querying a large oncology database with generative AI - West et al. @tempusAI #ASCO25 Abstract e13589 https://t.co/FPjKzFJZsb #hemonc https://t.co/KgHg97TjUx
-
-
Mashup Score: 10Program Guide – ASCO Meeting Program Guide - 8 day(s) ago
Albert Grinshpun Shaare Zedek Medical Center, Jerusalem, Israel Albert Grinshpun, Binyam Yilma, Daniela Katz, Adar Yaacov, Karyn Ronski, Stamatina Fragkogianni, Calvin Chao Shaare Zedek Medical Center, Jerusalem, Israel, Tempus AI, Chicago, IL, Hadassah Medical Center, Jerusalem, Israel, TEMPUS Lab, Chicago, IL, Tempus AI, Inc., Chicago, IL Activating mutations in the ER, encoded by the ESR1 gene (ESR1 mt), result in a constitutively active receptor and emerge as a resistance mechanism following endocrine
Source: meetings.asco.orgCategories: General Medicine NewsTweet-
ESR1 mutations and associated alterations in patients with estrogen receptor (ER+), HER2-positive (HER2+) breast cancers at diagnosis of metastatic disease (mBC) - @AlbertGrinshpun et al. #ASCO25 Abstract e13035 https://t.co/05j6eSOw6A @TempusAI #bcsm #PrecisionMedicine
-
-
Mashup Score: 4Program Guide – ASCO Meeting Program Guide - 8 day(s) ago
Joshua Pothen University of Illinois Chicago, Chicago, IL Joshua Pothen, Jen Godden, Denise Shieh, Stamatina Fragkogianni, Jacob Mercer, Melissa Stoppler, Daniel Principe, Ryan Nguyen, Kamya Sankar, Koosha Paydary, Mary Fidler, Frank Weinberg University of Illinois Chicago, Chicago, IL, Tempus AI, Chicago, IL, TEMPUS AI, Chicago, IL, Tempus AI, Inc., Chicago, IL, University of Wisconsin, Madison, WI, University of Illinois College of Medicine, Chicago, IL, Cedars- Sinai Medical Center, Los Angeles, CA,
Source: meetings.asco.orgCategories: General Medicine NewsTweet-
Lipid metabolic gene expression and association with decreased overall survival and immunogenicity in KRAS-STK11 NSCLC - @drdrjoshua et al. #ASCO25 Abst 8534 https://t.co/uKuwhy98NZ @TempusAI #lcsm #PrecisionMedicine #cametab #caxtx https://t.co/1AxvMUZPHG
-
-
Mashup Score: 2Program Guide – ASCO Meeting Program Guide - 8 day(s) ago
Jay Lee Division of Thoracic Surgery, University of California, Los Angeles (UCLA), Los Angeles, CA Jay Lee, Brooke Rhead, Edward Garon, Jonathan Goldman, Maria Velez Velez, Arjan Gower, Aaron Lisberg, Paul Boutros, Steven Dubinett, Edward Williams, Catherine Traverso, Stamatina Fragkogianni, Michael Thompson, Jacob Mercer, Amy Cummings Division of Thoracic Surgery, University of California, Los Angeles (UCLA), Los Angeles, CA, Tempus AI, Inc., Chicago, IL, Division of Hematology/Oncology, University of
Source: meetings.asco.orgCategories: General Medicine NewsTweet-
ImmunoDriver-1: Driver alterations (dAlts) and their immunological implications in early and metastatic non-small cell lung cancer (NSCLC) - Lee et al. @UCLAHealth @TempusAI #ASCO25 Abst 8060 https://t.co/JheJE4f5Zs #lcsm #ImmunoOnc #PrecisionMedicine https://t.co/LbFPSGOjIC
-
-
Mashup Score: 4Program Guide – ASCO Meeting Program Guide - 8 day(s) ago
The abstract will be released to the public on May 22, 2025 at 9:00 PM UTC Robert Huether Tempus AI, Inc., Chicago, IL Robert Huether, Derick Hoskinson, Pavana Anur, Raul Torres, Karl Beutner, Kristiyana Kaneva, Yan Yang, Kelly Potts, Andrew Frazier, Iris Braunstein, Brett Mahon, Michael Thompson, Kate Sasser, Halla Nimeiri, Lewis Kraft, Francisco De La Vega, Alejandro Marinos Velarde Tempus AI, Inc., Chicago, IL, UT Southwestern Medical Center, Dallas, TX This material on this page is ©2025 American
Source: meetings.asco.orgCategories: General Medicine NewsTweet-
Detection of KMT2A partial tandem duplication (PTD) in AML by whole genome sequencing (WGS): Addressing limitations of traditional techniques in the era of revumenib approval - Huether et al. #ASCO25 Abst 6532 https://t.co/EEsXm7JGdv #AMLsm #leusm #PrecisionMedicine @TempusAI
-
-
Mashup Score: 9Program Guide – ASCO Meeting Program Guide - 8 day(s) ago
Faran Polani Inova Schar Cancer Institute, Fairfax, VA Faran Polani, Edward Williams, Metamia Ciampricotti, Binyam Yilma, Stamatina Fragkogianni, Charlie Johnson, Melissa Stoppler, Timothy Cannon Colorectal cancer (CRC) is a leading cause of cancer-related mortality, with 20-25% of cases presenting with metastatic disease (mCRC). Pathogenic variants in the GNAS gene, which encodes the stimulatory alpha subunit of the G protein complex, are found in 1.5% to 4.8% of CRC cases and are more prevalent in
Source: meetings.asco.orgCategories: General Medicine NewsTweet-
Clinicogenomic landscape and outcomes of metastatic colorectal cancer patients with pathogenic GNAS variants - @polanimd et al. #ASCO25 Abst 3572 https://t.co/SggYVYy6Jg @TempusAI #crcsm #PrecisionMedicine https://t.co/4g07MseZQ0
-
-
Mashup Score: 7Program Guide – ASCO Meeting Program Guide - 8 day(s) ago
Vittorio Studiale Unit of Medical Oncology 2, Azienda Ospedaliera Universitaria Pisana and Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy Vittorio Studiale, Kristiyana Kaneva, Roberto Moretto, Farahnaz Islam, Guglielmo Vetere, Daniel Neems, Christine Lo, Robert Tell, Seung Won Hyun, Veronica Conca, Chithra Sangli, Ada Taravella, Matteo Landi, Filippo Ghelardi, Kate Sasser, Sabina Murgioni, Michele Prisciandaro, Riccardo Cerantola, Ha lla
Source: meetings.asco.orgCategories: General Medicine NewsTweet-
Circulating tumor DNA (ctDNA) dynamics in liver-limited metastatic colorectal cancer (mCRC) patients resected after first-line systemic treatment - @VStudiale et al. @AoupPisana @TempusAI #ASCO25 Abst 3544 https://t.co/2sUOzooaTK #crcsm #MRD #LiquidBiopsy #PrecisionMedicine https://t.co/D9dlUPuOwj
-
-
Mashup Score: 1Program Guide – ASCO Meeting Program Guide - 8 day(s) ago
Samer Alkassis UCLA Health Jonsson Comprehensive Cancer Center, Los Angeles, CA Samer Alkassis, Marla Lipsyc-Sharf, Catherine Traverso, Adam Dugan, Binyam Yilma, Yuan Yuan, Funda Meric-Bernstam, Hope Rugo, Joyce O’Shaughnessy, Mothaffar Rimawi, Rachel Schiff, David Elashoff, John Glaspy, Martina Mcdermott, Amy Cummings, Jessica Symons, Stamatina Fragkogianni, Jacob Mercer, Calvin Chao, Aditya Bardia UCLA Health Jonsson Comprehensive Cancer Center, Los Angeles, CA, Te mpus AI, Inc., Chicago, IL, Cedars-Sina
Source: meetings.asco.orgCategories: General Medicine NewsTweet-
Transcriptomic biomarkers of therapeutic response to antibody-drug conjugates in metastatic breast cancer: A comprehensive multi-center study - @AlkassisSamer et al. #ASCO25 Abst 1041 https://t.co/nLOmqifTah @TempusAI #bcsm #caxtx
-
-
Mashup Score: 4Program Guide – ASCO Meeting Program Guide - 8 day(s) ago
Douglas Palmer AstraZeneca, Gaithersburg, MD Douglas Palmer, Virginia Rhodes, Fred Hirsch, Asrar Alahmadi, Amy Cummings, Christine Lovly, Raymond Osarogiagbon, Christopher Gilbert, Vincenzo Graziano, Jorge Blando, Ezra Cohen, Melissa Maggart AstraZeneca, Gaithersburg, MD, Tempus, AI, Inc., Chicago, IL, Mount Sinai Medical Center, New York, NY, The Ohio State University Wexner Medical Center, Columbus, OH, University of California Los Angeles Translational Oncology Research, Santa Monica, CA, Vanderbilt
Source: meetings.asco.orgCategories: General Medicine NewsTweet-
GEMINI-NSCLC study: Integrated longitudinal multi-omic biomarker profiling study of non-small cell lung cancer (NSCLC) patients - Palmer et al. #ASCO25 Abst TPS8114 https://t.co/Ujru3F9jcP @TempusAI @AstraZeneca #LiquidBiopsy #ImmunoOnc #oncorad https://t.co/UV4nftqq6g
-
Outcomes for patients with SPOP-mutated castration-resistant prostate cancer (CRPC) treated with an androgen receptor pathway inhibitor (ARPI) - Park et al. #ASCO25 Abst e17085 https://t.co/HC7YCTQg1N @TempusAI #pcsm